Peak6 Investments LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $170,722 - $301,500	-4,309 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $154,403 - $219,311	-2,658 Reduced 38.15%	4,309 $286,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $286,937 - $417,578	-4,915 Reduced 41.37%	6,967 $435,000
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $90,552 - $131,596	1,457 Added 13.98%	11,882 $984,000
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $95,521 - $140,861	-1,557 Reduced 12.99%	10,425 $691,000
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $196,445 - $382,713	4,483 Added 59.78%	11,982 $919,000
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $28,959 - $44,707	872 Added 13.16%	7,499 $322,000
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $289,827 - $480,123	-11,096 Reduced 62.61%	6,627 $286,000
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $194,415 - $596,862	9,456 Added 114.38%	17,723 $510,000
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $926,171 - $2.4 Million	-32,913 Reduced 79.92%	8,267 $524,000
Q3 2019 Nov 08, 2019	BUY	$26.26 - $34.86 $1.08 Million - $1.44 Million	41,180 New	41,180 $1.16 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.